ADVANCED — Sales to customers (Note 9)
Johnson & Johnson ADVANCED — Sales to customers (Note 9) decreased by 4.4% to $1.12B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 4.7%, from $1.07B to $1.12B. Over 4 years (FY 2021 to FY 2025), ADVANCED — Sales to customers (Note 9) shows relatively stable performance with a -0.2% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
Analysis
How to read this metric
An increase indicates growing market adoption and successful commercialization of advanced product offerings, while a decrease may signal competitive pressure or product lifecycle maturity.
Detailed definition
This metric represents the total revenue generated from the Advanced product segment, reflecting the market demand for t...
Peer comparison
Comparable to segment-specific revenue reporting in medical device or pharmaceutical peers, often benchmarked against total segment revenue growth rates.
jnj_segment_advanced_sales_to_customers_note_9Historical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $1.17B | $1.14B | $1.19B | $1.15B | $1.16B | $1.16B | $1.11B | $1.12B | $1.22B | $1.16B | $1.17B | $1.09B | $1.14B | $1.11B | $1.15B | $1.07B | $1.16B | $1.17B | $1.18B | $1.12B |
| QoQ Change | — | -2.1% | +4.2% | -3.9% | +0.9% | +0.2% | -4.2% | +0.8% | +9.3% | -4.7% | +0.3% | -6.9% | +5.0% | -2.8% | +3.8% | -6.8% | +8.5% | +0.1% | +0.9% | -4.4% |
| YoY Change | — | — | — | — | -1.0% | +1.2% | -7.0% | -2.4% | +5.7% | +0.5% | +5.2% | -2.8% | -6.6% | -4.7% | -1.4% | -1.3% | +2.0% | +5.0% | +2.1% | +4.7% |
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Johnson & Johnson's advanced — sales to customers (note 9)?
- Johnson & Johnson (JNJ) reported advanced — sales to customers (note 9) of $1.12B in Q1 2026.
- How has Johnson & Johnson's advanced — sales to customers (note 9) changed year-over-year?
- Johnson & Johnson's advanced — sales to customers (note 9) increased by 4.7% year-over-year, from $1.07B to $1.12B.
- What is the long-term trend for Johnson & Johnson's advanced — sales to customers (note 9)?
- Over 4 years (2021 to 2025), Johnson & Johnson's advanced — sales to customers (note 9) has grown at a -0.2% compound annual growth rate (CAGR), from $4.62B to $4.58B.
- What does advanced — sales to customers (note 9) mean?
- The total revenue earned from the company's Advanced product line.